Biosynthesis of lactacystin as a proteasome inhibitor

Abstract Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and...

Full description

Saved in:
Bibliographic Details
Main Authors: Takeshi Tsunoda, Shunkichi Furumura, Haruka Yamazaki, Chitose Maruyama, Yoshimitsu Hamano, Yasushi Ogasawara, Tohru Dairi
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Communications Chemistry
Online Access:https://doi.org/10.1038/s42004-025-01406-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594908063465472
author Takeshi Tsunoda
Shunkichi Furumura
Haruka Yamazaki
Chitose Maruyama
Yoshimitsu Hamano
Yasushi Ogasawara
Tohru Dairi
author_facet Takeshi Tsunoda
Shunkichi Furumura
Haruka Yamazaki
Chitose Maruyama
Yoshimitsu Hamano
Yasushi Ogasawara
Tohru Dairi
author_sort Takeshi Tsunoda
collection DOAJ
description Abstract Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and heterologous expression experiments. We also examined the functions of the genes encoding a PKS/NRPS hybrid protein (LctA), NRPS (LctB), ketosynthase-like cyclase (LctC), cytochrome P450 (LctD), MbtH-like protein (LctE), and formyltransferase (LctF) by in vivo and in vitro experiments. In particular, we demonstrated that LctF directly transferred the formyl group of 10-N-formyl tetrahydrofolate to CoA. The formyl group of formyl-CoA was then transferred to ACP1 by LctA_AT1 to form formyl-ACP1. This is the first example of an AT domain recognizing a formyl group. The formyl group is perhaps transferred to methylmalonate tethered on LctA_ACP2 to yield methylmalonyl-semialdehyde-ACP2. Then, it would be condensed with leucine bound to PCP in LctB by the C domain in LctA. Using a mimic compound, we confirmed that LctC catalyzed the formation of the cyclic α,α-disubstituted amino acid structure with concomitant release of the product from PCP. Thus, we figured out the overall biosynthesis of lactacystin including a novel role of a formyl group in a secondary metabolite.
format Article
id doaj-art-7152d142ee7440b39983074ec7cd44bb
institution Kabale University
issn 2399-3669
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Communications Chemistry
spelling doaj-art-7152d142ee7440b39983074ec7cd44bb2025-01-19T12:13:12ZengNature PortfolioCommunications Chemistry2399-36692025-01-01811810.1038/s42004-025-01406-4Biosynthesis of lactacystin as a proteasome inhibitorTakeshi Tsunoda0Shunkichi Furumura1Haruka Yamazaki2Chitose Maruyama3Yoshimitsu Hamano4Yasushi Ogasawara5Tohru Dairi6Graduate School of Engineering, Hokkaido University, N13-W8, Kita-ku, SapporoGraduate School of Chemical Sciences and Engineering, Hokkaido University, N13-W8, Kita-ku, SapporoGraduate School of Chemical Sciences and Engineering, Hokkaido University, N13-W8, Kita-ku, SapporoGraduate School of Bioscience and Biotechnology, Fukui Prefectural University, Eiheiji-choGraduate School of Bioscience and Biotechnology, Fukui Prefectural University, Eiheiji-choGraduate School of Engineering, Hokkaido University, N13-W8, Kita-ku, SapporoGraduate School of Engineering, Hokkaido University, N13-W8, Kita-ku, SapporoAbstract Lactacystin is an irreversible proteasome inhibitor isolated from Streptomyces lactacystinicus. Despite its importance for its biological activity, the biosynthesis of lactacystin remains unknown. In this study, we identified the lactacystin biosynthetic gene cluster by gene disruption and heterologous expression experiments. We also examined the functions of the genes encoding a PKS/NRPS hybrid protein (LctA), NRPS (LctB), ketosynthase-like cyclase (LctC), cytochrome P450 (LctD), MbtH-like protein (LctE), and formyltransferase (LctF) by in vivo and in vitro experiments. In particular, we demonstrated that LctF directly transferred the formyl group of 10-N-formyl tetrahydrofolate to CoA. The formyl group of formyl-CoA was then transferred to ACP1 by LctA_AT1 to form formyl-ACP1. This is the first example of an AT domain recognizing a formyl group. The formyl group is perhaps transferred to methylmalonate tethered on LctA_ACP2 to yield methylmalonyl-semialdehyde-ACP2. Then, it would be condensed with leucine bound to PCP in LctB by the C domain in LctA. Using a mimic compound, we confirmed that LctC catalyzed the formation of the cyclic α,α-disubstituted amino acid structure with concomitant release of the product from PCP. Thus, we figured out the overall biosynthesis of lactacystin including a novel role of a formyl group in a secondary metabolite.https://doi.org/10.1038/s42004-025-01406-4
spellingShingle Takeshi Tsunoda
Shunkichi Furumura
Haruka Yamazaki
Chitose Maruyama
Yoshimitsu Hamano
Yasushi Ogasawara
Tohru Dairi
Biosynthesis of lactacystin as a proteasome inhibitor
Communications Chemistry
title Biosynthesis of lactacystin as a proteasome inhibitor
title_full Biosynthesis of lactacystin as a proteasome inhibitor
title_fullStr Biosynthesis of lactacystin as a proteasome inhibitor
title_full_unstemmed Biosynthesis of lactacystin as a proteasome inhibitor
title_short Biosynthesis of lactacystin as a proteasome inhibitor
title_sort biosynthesis of lactacystin as a proteasome inhibitor
url https://doi.org/10.1038/s42004-025-01406-4
work_keys_str_mv AT takeshitsunoda biosynthesisoflactacystinasaproteasomeinhibitor
AT shunkichifurumura biosynthesisoflactacystinasaproteasomeinhibitor
AT harukayamazaki biosynthesisoflactacystinasaproteasomeinhibitor
AT chitosemaruyama biosynthesisoflactacystinasaproteasomeinhibitor
AT yoshimitsuhamano biosynthesisoflactacystinasaproteasomeinhibitor
AT yasushiogasawara biosynthesisoflactacystinasaproteasomeinhibitor
AT tohrudairi biosynthesisoflactacystinasaproteasomeinhibitor